Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Carboplatin Induction for Stage II/III Breast Cancer
NCT00107510Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Aug 2005
- Primary completion
- Sep 2007
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, carboplatin in breast cancer, sponsored by Cancer and Leukemia Group B. Started Aug 2005; status: completed.
02
Drugs
docetaxelcarboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00107510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107510.